Astellas Stock Replacement Program

The Astellas Stock Replacement Program provides stock replacement of injectable/infused Astellas products, including AmBisome® (amphotericin B) liposome for injection, at no cost, for medications administered to eligible, uninsured patients who meet program requirements.

AmBisome® is a registered trademark of Gilead Sciences, Inc.